COARE Holdings Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

COARE Holdings General Information

Description

Developer of cancer therapeutics designed to eradicate cancer stem cells and metastatic processes. The company specializes in immunotherapy, nanomedicine, and targeted drug discovery technologies for aggressive cancers, enabling patients to access treatments that address tumor growth and disease progression.

Contact Information

Website
www.coareholdings.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 755 Research Parkway
  • Oklahoma City, OK 73104
  • United States
+1 (405)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, HealthTech, Life Sciences, Oncology
Corporate Office
  • 755 Research Parkway
  • Oklahoma City, OK 73104
  • United States
+1 (405)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

COARE Holdings Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Seed Round In Progress Pre-Clinical Trials
9. Secondary Transaction - Private 01-Jul-2026 Completed Pre-Clinical Trials
8. Grant 22-Aug-2021 Completed Generating Revenue
7. Grant 22-Aug-2018 Completed Generating Revenue
6. Seed Round 06-Dec-2016 Cancelled Generating Revenue
5. Grant 22-Jul-2016 Completed Generating Revenue
4. Grant 31-Dec-2015 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 28-Feb-2014 $240K Completed Generating Revenue
1. Grant 23-Aug-2013 $220K Completed Generating Revenue
To view COARE Holdings’s complete valuation and funding history, request access »

COARE Holdings Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

COARE Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019112978-A2 Anti-dclk1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof Inactive 04-Dec-2017
WO-2019112978-A3 Anti-dclk1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof Inactive 04-Dec-2017

COARE Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

COARE Holdings FAQs

  • When was COARE Holdings founded?

    COARE Holdings was founded in 2010.

  • Where is COARE Holdings headquartered?

    COARE Holdings is headquartered in Oklahoma City, OK.

  • What is the size of COARE Holdings?

    COARE Holdings has 3 total employees.

  • What industry is COARE Holdings in?

    COARE Holdings’s primary industry is Drug Discovery.

  • Is COARE Holdings a private or public company?

    COARE Holdings is a Private company.

  • What is COARE Holdings’s current revenue?

    The current revenue for COARE Holdings is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process